STOCK TITAN

HEALTHLYNKED (HLYK) Stock News, Mar-Aug 2023

HLYK OTC

HealthLynked Corp. reports developments around its healthcare technology platform for patient engagement, care access, medical-record connectivity, and provider networking. Recurring updates cover the HealthLynked Network, the ARI AI health assistant, consumer and provider digital platforms, telehealth and appointment tools, and enterprise partnerships tied to payer, employer, and value-based care channels.

Company news also includes MedOfficeDirect medical-supply e-commerce activity, patent filings involving AI and patient record management, board and executive appointments, and capital-structure actions such as its completed reverse stock split. These updates frame HealthLynked as an OTCQB-traded healthcare technology issuer building digital tools for care navigation and healthcare data access.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.57%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.06%
Tags
none
-
News
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.47%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.86%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.25%
Tags
management
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.53%
Tags
Rhea-AI Summary

HealthLynked Corp. (OTCQB: HLYK) reported its financial results for the year and fourth quarter ending December 31, 2022. Revenue fell by 10% to $5.86 million compared to $6.50 million in 2021, primarily due to decreased patient service revenues. An impairment charge of $2.75 million was taken for intangible assets linked to MedOfficeDirect, which has faced declining revenues. However, the company anticipates revenue growth in 2023 from recent initiatives and acquired practices. Net losses decreased to $8.82 million in 2022 from $10.41 million in 2021. The company sold its ACO/MSO business in January 2023 and expects additional payments from this transaction by July 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.56%
Tags
-
Rhea-AI Summary

HealthLynked Corp. announced the granting of Patent No. 11,600,395 by the USPTO for its innovative technology enabling secure patient access via healthcare service provider-specific wireless access points. This patent allows secure communication between patients, providers, and third-party services, enhancing data security and streamlining interactions. CEO Michael Dent emphasized the significance of this milestone in advancing patient-centric solutions in healthcare. The patent positions HealthLynked favorably in the digital healthcare market, offering a competitive edge and facilitating the development of more efficient healthcare services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.95%
Tags
none
-
Rhea-AI Summary

HealthLynked (OTCQB: HLYK) announced the appointment of Paul J. Hobaica, MD, to its Board of Directors, succeeding Robert P. Mino, JD, MBA, MS. Dr. Hobaica brings over 25 years of medical experience and serves as Corporate Medical Director at Arthrex Medical Center. His expertise in internal and occupational medicine is expected to enhance HealthLynked's strategic direction, particularly in developing partnerships and services aimed at improving healthcare outcomes. CEO Michael Dent expressed confidence that Dr. Hobaica's leadership will support the company's mission to leverage technology for better healthcare.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.3%
Tags
management
Rhea-AI Summary

HealthLynked, a prominent digital healthcare solutions provider, has unveiled its new Online Concierge service, enhancing the patient experience for booking physician appointments. This service allows patients to schedule appointments with over 880,000 healthcare providers nationwide through the HealthLynked Network. Patients can select specific times for their appointments, with support from HealthLynked's concierge team for unclaimed listings. A free 30-day trial is available, after which membership plans start at $10/month. The service prioritizes patient privacy, ensuring no healthcare information is shared with third parties.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5%
Tags
none

FAQ

What is the current stock price of HEALTHLYNKED (HLYK)?

HEALTHLYNKED (HLYK) last closed at $2.088.

What is the market cap of HEALTHLYNKED (HLYK)?

The market cap of HEALTHLYNKED (HLYK) is approximately $6.2M.